David R. Smith joined Charles River with the acquisition of Argenta and BioFocus in April 2014. Mr. Smith assumed the role of Corporate Vice President, Charles River Early Discovery Services, following the completion of the acquisition, and in October 2014, was promoted to Corporate Senior Vice President, Global Discovery Services. In August 2015, Mr. Smith was promoted to Corporate Executive Vice President and Chief Financial Officer. In this role, Mr. Smith leads the Company’s global finance organization and is responsible for overseeing Accounting, Tax, Treasury, Investor Relations, and Internal Audit. He is a member of the company’s Executive Committee.
Prior to joining Charles River, Mr. Smith had been Chief Executive Officer of Galapagos Services, the contract research services division of Belgian biotech Galapagos NV, which included Argenta and BioFocus. He had held this position since August 2013. Previously, he was Chief Financial Officer of Cambridge University Hospitals from 2007 to 2013, and of Galapagos NV between 2006 and 2007, during which time he played a key role in several merger and acquisition projects to build the services division. Mr. Smith held Marketing Company Chief Financial Officer and R&D Finance roles within AstraZeneca in the United Kingdom, Sweden, Hungary, and the Netherlands from 1997 to 2005, and worked as a Chartered Accountant with PricewaterhouseCoopers in the United Kingdom and Dubai between 1989 and 1997.
Mr. Smith received a B.Sc. Honours degree in Molecular Biophysics from the University of Leeds.